Lv1
10 积分 2025-06-06 加入
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
2个月前
已完结
Myeloproliferative Neoplasms
3个月前
已完结
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
3个月前
已完结
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
5个月前
已完结
Development and Clinical Indications of Cetuximab
5个月前
已完结
Progress of ATM inhibitors: opportunities and challenges
6个月前
已完结
Targeting ATR in patients with cancer
6个月前
已完结
DNA Damage Repair Inhibitors—Combination Therapies
6个月前
已完结
DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications
6个月前
已完结
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial
7个月前
已完结
皖公网安备34019202002308